Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

Annals of Hematology

Volumn 82, Issue 6, 2003, Pages 336-342

  Krooger N ^a   Bornhauser M ^b   Ehninger, G ^b   Schwerdtfeger, R ^c   Biersack, H ^d   Sayer, H G ^e   Wandt, H ^f   Schafer Eckardt K ^f   Beyer, J ^g   Kiehl, M ^h   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Bone Marrow Transplantation ^*  (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f KLINIKUM NÜRNBERG   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h Bone Marrow Transplantation Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CAUSE OF DEATH; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DONOR; DRUG DOSE REDUCTION; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKOCYTE TRANSFUSION; MALE; MALIGNANT TRANSFORMATION; MYCOSIS; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL; PRELEUKEMIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIDE EFFECT; STANDARDIZATION; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 10744229703     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0654-9     Document Type: Article

References (14)

1. Bennett JM, Catovsky D, Daniel MD, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of myelodysplastic syndromes. Br J Haematol 51:189-199
2. De Witte T, Hermans J, Vossen J, Bacigalupo A, Meloni G, Jacobsen N, Ruutu T, Ljungman P, Gratwohl A, Runde V, Niederwieser D, van Biezen A, Devergie A, Cornelissen J, Jouet JP, Arnold R, Apperley J (2000) Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 110:620-630
3. Slavin S, Nagler A, Naperstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant diseases. Blood 91:756-763
4. Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Korbling M, Keating M, Kantarjian H, Champlin R (1997) Engraftment of allogeneic hematopoietic progenitor cells with purin analog-containing chemotherapy: harnessing graft versus leukemia effect without myeloablative therapy. Blood 89:4531-4536
5. McSweeney P, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu C, Blume KG, Storb RF (2001) Hematopoietic cell transplantation in older patients with hematological malignancies: replacing high-dose cytotoxic therapy with graft versus tumor effects. Blood 97:3390-3400
6. Child R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman D, Read EJ, Carter C, Bahceci E, Young NS, Barrett AJ (1999). Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 94:3234-3241
7. Köger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR (2001) A fludarabine-based dose-reduced conditioning followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Bone Marrow Transplant 28:643-647
8. Martino R, Caballero MD, Perez Simon JA, Canals C, Solano C, Urbano-Ispizua A, Bargay J, Leon A, Sarra J, Sanz GF, Moraleda JM, Brunet S, San Miguel J, Sierra J (2002) Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. Blood 100:2243-2245
9. Przepiorka KM, Weisdorf D, Martin P (1995) 1994 Consensus Conference on acute GVHD-grading. Bone Marrow Transplant 15:825-828
10. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-460
11. Appelbaum FR, Anderson J (1998) Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcome analysis according the IPSS score. Leukemia 12:25-29
12. Sierra J, Perez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaertts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, deWitte TM, Horowitz MM (2002) Bone marrow-transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 100:1997-2004
13. Rezvani K, Lalancette, Szydlo R (2000) Non-myeloablative stem cell transplant in AML, ALL, and MDS: disappointing outcome for patients with advanced phase disease. Blood 96 [Suppl]:2061
14. Parker J, Shafi T, Pagliuca A, Mijovic A, Devereux S, Potter M, Prentice HG, Garg M, Yin JA, Byrne J, Russel NH, Mufti GJ (2002) Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol 119:144-154